Cornercap Investment Counsel Inc Bristol Myers Squibb CO Transaction History

Cornercap Investment Counsel Inc

$600 Million
Q2 2024

A detailed history of Cornercap Investment Counsel Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 58,464 shares of BMY stock, worth $3.11 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

58,464

Previous 61,828 5.44%

Holding current value

$3.11 Million

Previous $3.35 Million 27.57%

% of portfolio

0.4%

Previous 0.53%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $135,401 - $178,258	-3,364 Reduced 5.44%	58,464 $2.43 Million
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $83,965 - $95,200	-1,750 Reduced 2.75%	61,828 $3.35 Million
Q4 2023 Jan 30, 2024	BUY	$48.48 - $57.85 $131,283 - $156,657	2,708 Added 4.45%	63,578 $3.26 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $316,889 - $354,332	5,474 Added 9.88%	60,870 $3.53 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $108,880 - $120,894	1,709 Added 3.18%	55,396 $3.54 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $55,327 - $62,754	842 Added 1.59%	53,687 $3.72 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $186,060 - $220,321	-2,717 Reduced 4.89%	52,845 $3.8 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $509 - $300,905	3,916 Added 7.58%	55,562 $3.95 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $267,314 - $294,406	-3,681 Reduced 6.65%	51,646 $3.98 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $77,034 - $92,371	1,253 Added 2.32%	55,327 $4.04 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $546,704 - $637,328	10,194 Added 23.23%	54,074 $3.37 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $26,804 - $31,397	-453 Reduced 1.02%	43,880 $2.6 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $38,941 - $42,407	629 Added 1.44%	44,333 $2.96 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $2.32 Million - $2.61 Million	39,098 Added 848.85%	43,704 $2.76 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $2.06 Million - $2.33 Million	-35,626 Reduced 88.55%	4,606 $296,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $2.31 Million - $2.56 Million	40,232 New	40,232 $2.43 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $213,718 - $310,582	-4,606 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $2.32 Million - $3.02 Million	-47,058 Reduced 91.08%	4,606 $296,000
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $113,340 - $134,381	-2,650 Reduced 4.88%	51,664 $2.62 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $36,856 - $40,754	-826 Reduced 1.5%	54,314 $2.46 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $17,371 - $20,713	385 Added 0.7%	55,140 $2.63 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $1.25 Million - $1.62 Million	25,683 Added 88.34%	54,755 $2.85 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $1.6 Million - $1.81 Million	29,072 New	29,072 $1.81 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Account

Cornercap Investment Counsel Inc Bristol Myers Squibb CO Transaction History